Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • honey
    Senior Member
    • Feb 2010
    • 151

    #1

    Question about gene expression array analysis

    My apology about a dumb question about old gene expression array:

    I have a custom array gene expression data with controls and Cancer as log transformed RMA normalized values. If I have to calculate fold chnage or difference in cancer and normal tissues -
    I will simply take difference of values cancer - normal and it will be log fold change and then if I want in linear scale I can take antilog of this difference.
    Could some one advice if I am thinking correctly or I am doing something wrong. Again my apology for this basic question.

    Thanks.
  • jiaco
    Member
    • May 2010
    • 35

    #2
    If you have log2 data and geneA is 8.0 in cancer and 6.0 in control, you have a 2.0 log2ratio (cancer-control). Which is 2^2 = 4 in fold change. But the ratio in (control-cancer) is -2 and 2^-2 is 0.25. If you prefer to see -4 in fold change, then use something like this (in R)

    a = log2ratio
    b = result (fold change)

    if(a<0){b=-1*(2^abs(a))}else{b=2^a}

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...